-$127 Loss
VSTMLong Stock
Sold to soon went up on news in a few days. Verastem announces that the FDA accepted for filing with Priority Review its New Drug Application for its lead product candidate duvelisib VSTM
Broker:ETrade
| Date | Price | |
|---|---|---|
| Entry | 4/9/2018 | 3.30 |
| Exit | 4/9/2018 | 3.23 |
- Total Views96
- Position Size1,667
- Percentage-2.12%
Copy and paste the following into your page or blog. If using WordPress, you must paste this in the HTML tab only:
